Russian Pharma Company Biocad Obtains European Certification for Biosimilars to Treat Cancer

Publication Date04 April 2020
SubjectPrescription Drugs,Russia,Biosimilars,Pharmaceutical Industry
Law FirmGoodwin

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT